- Scotiabank analyst Greg McGinniss sets a new price target of $43 for NASDAQ:LINE, indicating a potential upside of 5.94%.
- The stock’s volatility is highlighted by its year-long fluctuation between $84.86 and $38.83.
- Rosen Law Firm encourages investors to seek legal counsel ahead of a lead plaintiff deadline, potentially affecting investor sentiment and stock performance.
Lineage, Inc. (NASDAQ: LINE) is a company that has recently caught the attention of investors and analysts alike. On September 5, 2025, Greg McGinniss from Scotiabank set a price target of $43 for LINE, which was trading at $40.59 at the time. This suggests a potential upside of about 5.94%. However, this target was revised down from a previous target of $49, as reported by TheFly.
The stock’s current price of $40.59 reflects a slight increase of 0.32% today, equivalent to a $0.13 rise. Throughout the day, LINE’s price has fluctuated between $39.87 and $41.36. Over the past year, the stock has experienced significant volatility, with a high of $84.86 and a low of $38.83. This volatility may be a factor in the revised price target.
Lineage’s market capitalization is approximately $9.29 billion, indicating its substantial presence in the market. The trading volume today is 889,246 shares, which shows active investor interest. Despite the recent price target adjustment, the stock’s market activity suggests continued investor engagement.
Rosen Law Firm, a global investor rights law firm, is urging investors of Lineage to seek legal counsel due to an upcoming lead plaintiff deadline on September 30, 2025. This call is directed at those who purchased Lineage’s common stock during its IPO in July 2024. The legal proceedings could impact investor sentiment and the stock’s future performance.
Investors should consider both the revised price target and the ongoing legal matters when evaluating NASDAQ:LINE. The potential upside, market activity, and legal developments are all crucial factors that could influence the stock’s trajectory in the coming months.